Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

NIH Grant Funds New Spinal Cord Injury Treatment

Spine

A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury. . . . → Read More: NIH Grant Funds New Spinal Cord Injury Treatment

Engineered Polio Virus Tested as Brain Cancer Treatment

Brain tumor graphic

Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment

Univ. Spin-Off Developing Long-Lasting Diabetes Drug

Bathroom scale

A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight. . . . → Read More: Univ. Spin-Off Developing Long-Lasting Diabetes Drug

$3.4M NIH Grant Funding New ALS Treatments

Brain cell networks

A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments

NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Sickle cell illustration

The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Single Technology Produces Vaccines for Multiple Infectious Diseases

Ebola diagnostics

A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases

Data Tools Designed for Genomics-Based Precision Cancer Care

Computational biology illustration

A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care

Univ. Spinoff Qualifies for NIH Clinical Program

Kate Rittenhouse-Olson and John Fisk

An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program

Trial Underway Testing Universal Flu Vaccine

Influenza virus

A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year. . . . → Read More: Trial Underway Testing Universal Flu Vaccine

Global Health R&D Cuts Threaten U.S. Economy, Jobs

Children receiving vaccine

An analysis of the impact of proposed cuts in funds for research and development on technologies to address global health needs shows the U.S. economy benefits directly from this spending, including support of many jobs in nearly all states. . . . → Read More: Global Health R&D Cuts Threaten U.S. Economy, Jobs